BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 169 filers reported holding BRIDGEBIO PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $910,029 | +46.3% | 34,510 | -4.5% | 0.00% | – |
Q2 2023 | $621,866 | -0.3% | 36,155 | -3.9% | 0.00% | – |
Q1 2023 | $623,740 | +34.7% | 37,620 | -38.0% | 0.00% | – |
Q4 2022 | $463,000 | -24.0% | 60,717 | -0.9% | 0.00% | – |
Q3 2022 | $609,000 | +250.0% | 61,247 | +219.1% | 0.00% | – |
Q2 2022 | $174,000 | -74.2% | 19,195 | -52.5% | 0.00% | – |
Q4 2021 | $674,000 | -65.6% | 40,372 | -3.4% | 0.00% | -100.0% |
Q3 2021 | $1,960,000 | -16.5% | 41,812 | +8.5% | 0.00% | 0.0% |
Q2 2021 | $2,348,000 | +8.3% | 38,519 | +9.4% | 0.00% | 0.0% |
Q1 2021 | $2,169,000 | -28.4% | 35,211 | -17.3% | 0.00% | 0.0% |
Q4 2020 | $3,030,000 | +82.6% | 42,602 | -3.7% | 0.00% | 0.0% |
Q3 2020 | $1,659,000 | +8.7% | 44,239 | -5.5% | 0.00% | 0.0% |
Q2 2020 | $1,526,000 | -10.0% | 46,802 | -20.0% | 0.00% | 0.0% |
Q1 2020 | $1,696,000 | +66.9% | 58,492 | +101.9% | 0.00% | – |
Q4 2019 | $1,016,000 | +71.9% | 28,973 | +5.2% | 0.00% | – |
Q3 2019 | $591,000 | -12.7% | 27,544 | +9.7% | 0.00% | – |
Q2 2019 | $677,000 | – | 25,115 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 6,068,125 | $160,016,456 | 65.94% |
Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $819,077,805 | 28.79% |
Cormorant Asset Management, LP | 4,662,530 | $122,950,916 | 7.17% |
Frazier Life Sciences Management, L.P. | 2,725,949 | $71,883,275 | 4.77% |
Octagon Capital Advisors LP | 971,639 | $25,622,120 | 3.94% |
M28 Capital Management LP | 121,200 | $3,196,044 | 3.66% |
VIKING GLOBAL INVESTORS LP | 25,120,991 | $662,440,533 | 2.69% |
BOONE CAPITAL MANAGEMENT LLC | 313,381 | $8,263,857 | 2.61% |
Fernwood Investment Management, LLC | 235,620 | $6,213,299 | 2.23% |
SOUTHPORT MANAGEMENT, L.L.C. | 15,000 | $395,550 | 2.15% |